LEAD Conference for Women in Oncology

LEAD is a 2-day conference designed for women in oncology and hematology. The goal of this conference is to empower women leaders in the hematology and oncology space by providing essential clinical updates, career development, and professional networking. Sessions include discussions on the importance of women’s leadership, career development workshops, and clinical sessions on biomarkers and oncology therapies.

*Program is subject to change prior to conference.

Day 1: October 4, 2019

7:00 AM—8:00 AM	Breakfast and Registration One-on-One Mentoring Sessions
8:00 AM—8:05 AM	Welcome Remarks and Conference Overview
Plenary Session: The Importance of Women’s Leadership in Healthcare and Oncology
8:05 AM – 9:30 AM	Professional Vignettes and Panel Discussion: Women oncology leaders share their journeys and perspectives on the past and current state of women in healthcare and how they are amplifying women’s voices in oncology Linda Bosserman, MD \| City of Hope Vicki Goodman, MD \| Bristol-Myers Squibb Nicole Gormley, MD \| US Food and Drug Administration Sandra Horning \| Roche/Genentech Joyce O’Shaughnessy, MD \| Texas Oncology
9:20 AM – 9:30 AM	Panel Discussion and Participant Q&A Chair and Session Speakers
Session I: Focused Workshops, Part 1
9:30 AM – 10:15 AM	Burnout or Balance? Finding Resilience in an Age of Chronic Stress Barrett McBride, PhD
10:15 AM – 10:30 AM	Break
10:30 AM – 11:30 AM	Panel: Building Your Resiliency and Relationship Success Moderator: Barrett McBride, PhD Charu Aggarwal, MD, MPH \| U. of Pennsylvania Julie Brahmer, MD, MSc \| Johns Hopkins Medicine Elizabeth Comen, MD \| Memorial Sloan Kettering Alessandra Ferrajoli, MD \| MD Anderson Joyce O’Shaughnessy, MD \| Texas Oncology Rachna Shroff, MD \|U. of Arizona Cancer Center
11:30 AM – 12:15 PM	A Social Media Toolkit to Enhance Your Career Moderator: Shikha Jain, MD \| Rush U. Medical Center Stephanie Graff, MD \| Menorah Medical Center Tiffany Traina, MD \| Memorial Sloan Kettering
12:15 PM – 1:30 PM	Lunch
12:30 PM – 1:30 PM	Industry Product Theater
Session II: Impact of Emerging Biomarkers on Treatment Selection and Drug Development
1:30 PM – 1:50 PM	The Role of Biomarkers in the Development of PARP Inhibitors Joyce O’Shaughnessy, MD \| Texas Oncology
1:50 PM – 2:10 PM	When Biomarkers Define Indication – MSI, MMR, and Mutations Rachna Shroff, MD \| U. of Arizona Cancer Center
2:10 PM – 2:30 PM	Challenges with Biomarkers in Cancer Drug Development Lauren Byers, MD \| MD Anderson
2:30 PM – 2:45 PM	Panel Discussion and Participant Q&A Chair and Session Speakers
2:45 PM – 3:15 PM	Break
Session III and IV: Clinical Updates in Immuno-Oncology and Cell-based Therapies
3:15 PM – 3:35 PM	Patient Selection in Frontline Metastatic Lung Cancer Julie Brahmer, MD, MSc \| Johns Hopkins Medicine
3:35 PM – 3:55 PM	CAR T Cell Therapy: New Era of Therapy for B-Cell Malignancies Julie Vose, MD, MBA \| U. of Nebraska Medical Center
3:55 PM – 4:15 PM	Targeted Tumor Treatment with Antibody Drug Conjugates Sarah Hurvitz, MD \| UCLA
4:15 PM – 4:35 PM	Antibody Therapy as an Evolving SOC in Multiple Myeloma Nina Shah, MD \| UCSF
4:35 PM – 4:50 PM	Panel Discussion and Participant Q&A
4:50 PM – 5:25 PM	Immunotherapy for PD-L1 Positive or MSI-high Cervical Cancer Addressing Unmet Clinical Needs in Advanced Ovarian Cancer Claire Friedman, MD \| Memorial Sloan Kettering
5:25 PM – 5:45 PM	Treatment Evolution in Triple Negative Breast Tiffany Traina, MD \| Memorial Sloan Kettering
5:45 PM – 6:00 PM	Panel Discussion and Participant Q&A Chair and Session Speakers
6:00 PM – 7:00 PM	Evening Networking Reception

Day 2: October 5, 2019

6:30 AM – 7:30 AM	Sunrise Yoga
8:00 AM – 8:30 AM	Breakfast One-on-One Mentoring Sessions
Session V: Clinical Updates in Small-Molecule Targeted Inhibitors
8:30 AM – 8:50 AM	CLL: Reaching for Curative Potential Alessandra Ferrajoli, MD \| MD Anderson
8:50 AM – 9:10 AM	Targeted Inhibitors in EGFR-positive Lung Cancer Leora Horn, MD, MSc, FRCPR \| Vanderbilt Ingram Cancer Ctr
9:10 AM – 9:30 AM	Moving Beyond Checkpoint Inhibitors: New Treatment Options in Urothelial Cancer Arlene Siefker-Radtke, MD \| MD Anderson
9:30 AM – 9:45 AM	Panel Discussion and Participant Q&A Chair and Session Speakers
Session VI: Patient Management and Supportive Care in an Era of New Therapies
9:45 AM – 10:05 AM	Financial and Quality of Life Impact of Early Supportive Care Monica Malec, MD \| U. of Chicago
10:05 AM – 10:25 AM	Sexual Health and Fertility After Cancer Treatment for Women Anne Katz, PhD, RN \| CancerCare Manitoba
10:25 PM – 10:45 AM	Redefining Value with Modern Cancer Therapies Debra Patt, MD, MPH, MBA \| US Oncology
10:45 AM – 11:00 AM	Panel Discussion and Participant Q&A Chair and Session Speakers
11:00 AM – 11:20 AM	Break
Session VII: Focused Workshops, Part 2
11:20 AM – 12:05 PM	Panel: Building Your Brand Moderator: Nina Shah, MD \| UCSF Charu Aggarwal, MD, MPH \| U. of Pennsylvania Stephanie Graff, MD \| Menorah Medical Center Shikha Jain, MD \| Rush U. Medical Center
12:05 PM – 12:50 PM	Panel: Leaning Into Leadership Opportunities Moderator: Julie Vose, MD, MBA \| U. of Nebraska Medical Center Linda Bosserman, MD \| City of Hope Leora Horn, MD, MSc, FRCPC \| Vanderbilt Ingram Cancer Ctr Jane Meisel, MD \| Emory U. Winship Cancer Inst.
12:50 PM – 1:50 PM	Lunch
12:50 PM – 1:50 PM	Industry Product Theater
Session VIII: Focused Workshops, Part 3
1:50 PM – 3:20 PM	Transformational Leadership Margaret Moore, MBA \| Wellcoaches Corporation
3:20 PM – 3:50 PM	Keynote – Future of Women in Oncology Julie Vose, MD, MBA \| U. of Nebraska Medical Center
3:50 PM – 4:00 PM	Award Presentations: Woman Oncologist of the Year and Rising Star Sponsored by Women Leaders in Oncology Closing Remarks and Adjourn

Leadership. Empowerment. Development.

Day 1: October 4, 2019

Day 2: October 5, 2019